Demographic and clinical characteristics of study subjects
NAFLD
Among the 95 NAFLD patients who were screened, 37 patients were randomized, and 36 received placebo or ZSP1601 (50 mg QD, 50 mg BID, or 100 mg BID), and 36 (100%) completed the entire clinical study (Fig. 